A look ahead. This page shows the vision and future stages of Liver & Heart for investors and partners. Some capabilities described here are on our roadmap and are not yet available in your account.
AI prevention, patient identification and care navigation for metabolic health
Guiding millions through metabolic health — connecting risk awareness, specialist care and navigation in one shared ecosystem.
1 in 3
adults in Germany has fatty liver disease (MASLD).
Most don’t know it.
Source: EASL Steatotic Liver Disease Guidance, 2026.
Fatty liver disease is the most common chronic liver condition worldwide — and remains largely invisible. Liver & Heart builds the first scalable digital orientation infrastructure for those affected and the ecosystem that supports them.
A journey-driven, multi-stakeholder AI platform
One ecosystem connects patients, professionals, organisations and partners across a shared metabolic health journey.
Members & patients
Guided, empowered and supported through a structured health journey.
Professionals
Better insights, better outcomes and more contextual patient preparation.
Organisations
Smarter care delivery and coordination across teams, places and programmes.
Partners
Pilots, screening pathways and aggregated, privacy-safe programme insights.
One shared ecosystem, different interfaces, aligned incentives.
“Is my liver healthy?”
From first concern to measurable follow-up — supported by mobile check-ins, health-data capture and an appointment-ready passport.
- 1
Start moment
A short check-in to understand what triggered the concern and what matters now.
- 2
Health profile
Capture labs, history, medications, lifestyle and relevant metabolic information.
- 3
Risk & orientation
Understand relevant risk factors, screening options and the next steps to discuss.
- 4
Diagnostics & trials
Navigate to information about tests, scans, research and trial sites.
- 5
Care team
Find relevant professionals and care locations based on need and context.
- 6
Health goals
Turn the journey into achievable next steps, monitoring and follow-up.
Structured data layer: labs, habits, outcomes, adherence and journey drop-off points.
Privacy-first: consented, auditable and partner-ready by design.
Health happens between appointments
The mobile companion captures the daily signals that decide whether a journey becomes action.
The journey is the structure. The companion turns it into daily momentum.
Daily next step
The right action at the right moment, drawn from the journey.
Check-ins & signals
Symptoms, habits and measurements tracked over time.
Connected health data
Apple Health and Health Connect integration for context.
Contextual AI
Suggestions and answers grounded in the user’s journey — not a generic chatbot.
Appointment-ready passport
A clear summary to bring to the next consultation.
The full roadmap, on request
For partners and investors, we share the detailed product, regulatory and certification roadmap in direct conversations.
What the roadmap covers
Depth on the controlled beta, the regulated product pathway and structured partner pilots.
Product roadmap: mobile companion, health profile, passport and partner workflows.
Regulatory roadmap: MDR IIa/IIb module strategy, QMS, safety files and clinical evidence.
Market access: reimbursement readiness, certification milestones and partner pilots.
Request roadmap information
We are speaking with strategic and commercial partners who can help build the MASLD identification and care-navigation ecosystem.
Who we want to build with
We are looking for partners who help turn reach into an identification and care-navigation ecosystem.
Strategic partners
For investors and long-term ecosystem builders.
- Capital for platform growth
- Regulatory and clinical access
- Partner network and market access
- Long-term ecosystem value
Commercial partners
For measurable pilots and shared growth.
- Patient identification and journey activation
- Screening and referral optimisation
- Trial navigation pathways
- Aggregated, privacy-safe partner insights
Investor takeaway: We are not selling traffic. We are building identification, navigation and ecosystem infrastructure — and the data layer that makes it measurable.
A founder-led team behind Liver & Heart
Medicine, platform engineering, strategy and community-building in one team.
PD Dr. Maurice MichelSenior physician in hepatology, research group leader. 15+ years in clinical medicine and health research.
Christoph T. Michel, MBAStrategy manager, non-profit finance and operations leader. 15+ years in management.
Ronald StraussTech founder and platform builder, startup strategy and execution. 25+ years in enterprise IT.
Thomas VilcansPlatform and community founder, product owner and team lead. 25+ years in enterprise IT.
Launch safely. Learn fast. Certify the modules that matter.
We are preparing a controlled public beta while building the regulatory, clinical and product foundations for a certified metabolic-health information platform.